Table 1.
Correlations of VO2 peak with IMF:SM in cancer survivors and non-cancer comparators
IMF:SM correlation with VO2 peak | ||||||
---|---|---|---|---|---|---|
Adjusted for: | Overall study population (n = 28) |
Cancer Survivors (n = 14) |
Non-cancer comparators (n = 14) |
|||
r | p-value | r | p-value | r | p-value | |
N/Aa | −0.67 | 0.0001 | −0.54 | 0.044 | −0.72 | 0.004 |
Resting LVEF % | −0.70 | < 0.0001 | −0.59 | 0.035 | −0.74 | 0.004 |
Exercise-associated LVEF % | −0.71 | < 0.0001 | −0.54 | 0.055 | −0.85 | < 0.001 |
CVD risk factors | −0.64 | 0.0003 | −0.50 | 0.083 | −0.75 | 0.003 |
BMI | −0.67 | 0.001 | −0.58 | 0.040 | −0.71 | 0.007 |
SC fat | −0.61 | 0.007 | −0.50 | 0.080 | −0.70 | 0.008 |
IP fat | −0.60 | 0.001 | −0.56 | 0.047 | −0.59 | 0.033 |
aN/A: Correlation is not adjusted for any factors
LVEF left ventricular ejection fraction, IMF intermuscular fat, SM skeletal muscle, BMI body mass index, SC subcutaneous, IP intraperitoneal